Skip to main content
Addgene

VEE-mScarlet3-IRES-EGFP-IRES-moxBFP
(Plasmid #242407)

Print

Ordering

This material is available to academics and nonprofits only. Orders shipped outside the U.S. may require additional regulatory approval, as well as a non-refundable export license fee of $85. Please log in to view availability.
Item Catalog # Description Quantity Price (USD)
Plasmid 242407 Standard format: Plasmid sent in bacteria as agar stab 1 $89
Add to Cart

Backbone

  • Vector backbone
    Simplicon Cloning Vector
  • Backbone manufacturer
    Merck Millipore
  • Vector type
    Mammalian Expression ; Self-amplifying RNA

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert 1

  • Gene/Insert name
    mScarlet3
  • Species
    Synthetic

Gene/Insert 2

  • Gene/Insert name
    IRES-EGFP
  • Species
    Synthetic

Gene/Insert 3

  • Gene/Insert name
    IRES-moxBFP
  • Species
    Synthetic

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Please visit https://doi.org/10.1101/2024.09.24.614636 for the bioRxiv preprint.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    VEE-mScarlet3-IRES-EGFP-IRES-moxBFP was a gift from Ewan St. John Smith (Addgene plasmid # 242407 ; http://n2t.net/addgene:242407 ; RRID:Addgene_242407)

  • For your References section:

    Cap-independent co-expression of dsRNA-sensing and NF-κB pathway inhibitors enables controllable self-amplifying RNA expression with reduced immunotoxicity. Lim TKY, Ritoux A, Paine LW, Ferguson L, Abdul T, Grundy LJ, Smith ESJ. bioRxiv 2024.09.24.614636 10.1101/2024.09.24.614636
Related items: